{"nct_id":"NCT01009073","title":"A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer Subjects","status":"COMPLETED","status_verified_date":"2013-06","start_date":"2009-10","start_date_type":null,"primary_completion_date":"2013-06","primary_completion_date_type":"ACTUAL","completion_date":"2013-06","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ABBV"]}